Oncotelic

Vuong Trieu's photo - Chairman & CEO of Oncotelic

Chairman & CEO

Vuong Trieu

CEO Approval Rating

90/100

Founded:

1988

Status:

PrivateIndependent Company

ONCOTELIC TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Nkarta is Oncotelic's #1 competitor. Nkarta was founded in South San Francisco, California} in 2015. Like Oncotelic, Nkarta also competes in the Biotechnology industry. Compared to Oncotelic, Nkarta generates $115.4K more revenue.

Immune-Onc Therapeutics is one of Oncotelic's top competitors. Immune-Onc Therapeutics was founded in 2016 in Palo Alto, California. Like Oncotelic, Immune-Onc Therapeutics also operates in the Pharmaceuticals industry. Immune-Onc Therapeutics generates $5M more revenue than Oncotelic.

Pyxis Oncology is a top competitor of Oncotelic. Pyxis Oncology was founded in 2018, and is headquartered in Boston, Massachusetts. Like Oncotelic, Pyxis Oncology also competes in the Pharmaceuticals field. Pyxis Oncology generates $5.1M more revenue vs. Oncotelic.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apexigen a competitor of Oncotelic?

Oncotelic Acquisitions

No recent acquisitions found related to Oncotelic

Oncotelic Funding History

Since Oncotelic was founded in 1988, it has participated in 5 rounds of funding. In total Oncotelic has raised $13.3M. Oncotelic's last funding round was on Jun 2020 for a total of $2.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jun 2020
$2M
-
Debt - PPP (CARES Act)
Apr 2020
$250K
Debt
Apr 2019
$600K
-
Equity
Apr 2018
$2.9M
-
Equity
Mar 2010
$7.5M
-

Since Oncotelic was founded in 1988, it has participated in 5 rounds of funding. In total Oncotelic has raised $13.3M. Oncotelic's last funding round was on Jun 2020 for a total of $2.0M

Oncotelic Investments

No recent investments found related to Oncotelic

Oncotelic News

April 19, 2021Markets Insider

ONCOTELIC THERAPEUTICS, INC. ANNOUNCED SYNERGY BETWEEN OT-101 AND IL-2 (PROLEUKIN) AT AACR-2021

AGOURA HILLS, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ('Oncotelic' or... See more »
March 15, 2021MarketScreener

MATEON ANNOUNCES INITIATION OF PHASE 1B CLINICAL TRIAL ON OT-101/IL-2 COMBINATION THERAPY FOR SOLID TUMORS

(marketscreener.com) AGOURA HILLS, California, March 15, 2021 -- Mateon Therapeutics Inc. today annou... See more »
February 22, 2021Markets Insider

MATEON THERAPEUTICS AND WINDLAS BIOTECH LAUNCH INDIA'S FIRST COMBINED LUNG THERAPY AND AI TELEMEDICINE 360 SOLUTION TO TRANSFORM RESPIRATORY WELLNESS AT WWW.PULMOHEAL.COM

AGOURA HILLS, California, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) ("... See more »
February 1, 2021Markets Insider

MATEON LAUNCHES ITS AI TELEMEDICINE PLATFORM FOR POST MARKETING SURVEY TO SUPPORT ITS DRUG PRODUCT FOR INDIA, PULMOHEAL

AGOURA HILLS, California, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) ("... See more »
January 25, 2021MarketScreener

MATEON LAUNCHING MOBILE APP, ARTIHEALTH , FOR REMOTE RESPIRATORY HEALTH ASSESSMENT

(marketscreener.com) AGOURA HILLS, California, Jan. 25, 2021 -- Mateon Therapeutics, Inc. , a leading... See more »
December 30, 2020MarketScreener

MATEON'S GLOBAL STUDY FOR OT-101/ TGF- INHIBITOR AGAINST COVID-19 ENROLLS AND TREATS ITS FIRST PATIENT

(marketscreener.com) -FPI FOR C001 PHASE 2 TRIAL AGAINST COVID-19 AGOURA HILLS, Calif., Dec. 30, 2020... See more »
November 4, 2020MarketScreener

MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST COVID-19- RECEIVED CLEARANCE FOR PATIENT ENROLLMENT

(marketscreener.com) AGOURA HILLS, Calif., Nov. 04, 2020 -- Mateon Therapeutics, Inc. announced today... See more »

Oncotelic Press Releases

March 8, 2021GlobalNewswire

MATEON'S UPDATE ON C001 - GLOBAL STUDY FOR OT-101 AGAINST COVID-19

PART 1 AND 2 SENTINEL PATIENTS COMPLETED TREATMENT... See more »
March 1, 2021GlobalNewswire

MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH PULMOHEAL CLINICAL DATA AGAINST COVID-19 IN PEER-REVIEWED JOURNALS

AGOURA HILLS, California, March 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (... See more »
February 16, 2021StreetInsider

MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA

AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Â Mateon Therapeutics, Inc. (OTCQB:MATN) ... See more »
January 13, 2021GlobalNewswire

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC

AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (... See more »
December 9, 2020GlobalNewswire

MATEON TO HOST VIRTUAL WEBINAR ADDRESSING COVID-19 AND THERAPIES AYURVEDA AND ARTEMISIA ON DECEMBER 16, 2020

Agoura Hills, California, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. ("Mateon" or "O... See more »
December 9, 2020GlobalNewswire

MATEON TO HOST VIRTUAL WEBINAR ADDRESSING COVID-19 AND THERAPIES AYURVEDA AND ARTEMISIA ON DECEMBER 16, 2020

Agoura Hills, California, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. ("Mateon" or "O... See more »
November 30, 2020GlobalNewswire

DEVELOPMENT UPDATE FOR ARTIVEDA /ARTISHIELD AGAINST COVID-19

--75% IMPROVEMENT BY DAY 2 ON ARTIVEDA... See more »

Oncotelic Videos

Social Media

Oncotelic Headquarters

29397 Agoura Road Suite 107

Agoura Hills, California91301

650-635-7000

Driving Directions »

Trending Companies

Oncotelic Summary

ABOUT

Overview

Oncotelic was founded in 1988. Oncotelic's headquarters is located in Agoura Hills, California, USA 91301. It has raised 13.3M in 5 rounds. The latest round was in Jun 2020. Some of Oncotelic's investors include Silicon Valley Bank and Small Business...

CEO

Oncotelic's Chairman & CEO, Vuong Trieu, currently has an approval rating of 90%. Oncotelic's primary competitors are Nkarta, Immune-Onc Therapeutics & Pyxis Oncology.

Frequently Asked Questions about Oncotelic

  1. When was Oncotelic founded?

    Oncotelic was founded in 1988
  2. Who is Oncotelic's CEO?

    Oncotelic's CEO is Vuong Trieu
  3. How much revenue does Oncotelic generate?

    Oncotelic generates $ < 1M in revenue
  4. How much funding does Oncotelic have?

    Oncotelic has historically raised $13.3M in funding
  1. Where is Oncotelic's headquarters?

    Oncotelic's headquarters is in Agoura Hills California, USA
  2. How many employees does Oncotelic have?

    Oncotelic has 15 employees
  3. What sector does Oncotelic operate in?

    Oncotelic is in Pharmaceuticals, Biotechnology
  4. Who are Oncotelic's competitors?

    Oncotelic's top competitors are Nkarta, Immune-Onc Therapeutics, Pyxis Oncology